Sosei Group to Acquire Jitsubo

December 12, 2014

Sosei Group said it will acquire Jitsubo for about $3.6 million in a deal that will expand the buyer’s offerings beyond respiratory treatments to branded and generic peptide products.
GEN

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Sosei Group to Acquire Jitsubo

Upcoming Events

Optimizing Quality Control Operations with Unified Quality

Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

2023 WCG Avoca Quality Consortium Summit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

FDA Deems Cardiosave Intra-Aortic Balloon Recall Class I

Xtandi Shows Promise in Prostate Cancer Trial

Implantable Sleeve that Holds Spinal Screws in Place Gets FDA Clearance

FDA Green Lights Clinical Trial of Low-Dose Psilocybin

The Revised ICH E8: A Guide to New Clinical Trial Requirements